These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors. Dutta AK; Venkataraman SK; Fei XS; Kolhatkar R; Zhang S; Reith ME Bioorg Med Chem; 2004 Aug; 12(16):4361-73. PubMed ID: 15265488 [TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of 2-[4-[4-(m-(ethylsulfonamido)-phenyl) piperazin-1-yl]butyl]-1,3-dioxoperhydropyrrolo[1,2-c]imidazole (EF-7412) using neural networks. A selective derivative with mixed 5-HT1A/D2 antagonist properties. López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA; Schaper KJ Bioorg Med Chem Lett; 1999 Jun; 9(12):1679-82. PubMed ID: 10397500 [TBL] [Abstract][Full Text] [Related]
26. The impact of the halogen bonding on D Partyka A; Kurczab R; Canale V; Satała G; Marciniec K; Pasierb A; Jastrzębska-Więsek M; Pawłowski M; Wesołowska A; Bojarski AJ; Zajdel P Bioorg Med Chem; 2017 Jul; 25(14):3638-3648. PubMed ID: 28529043 [TBL] [Abstract][Full Text] [Related]
27. Rationally based efficacy tuning of selective dopamine d4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213). Löber S; Hübner H; Utz W; Gmeiner P J Med Chem; 2001 Aug; 44(17):2691-4. PubMed ID: 11495580 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties. López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA J Med Chem; 2001 Jan; 44(2):186-97. PubMed ID: 11170628 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors. Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145 [TBL] [Abstract][Full Text] [Related]
30. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo. Millan MJ; Svenningsson P; Ashby CR; Hill M; Egeland M; Dekeyne A; Brocco M; Di Cara B; Lejeune F; Thomasson N; Munoz C; Mocaër E; Crossman A; Cistarelli L; Girardon S; Iob L; Veiga S; Gobert A J Pharmacol Exp Ther; 2008 Feb; 324(2):600-11. PubMed ID: 18024787 [TBL] [Abstract][Full Text] [Related]
31. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor. Tallman JF; Primus RJ; Brodbeck R; Cornfield L; Meade R; Woodruff K; Ross P; Thurkauf A; Gallager DW J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370 [TBL] [Abstract][Full Text] [Related]
32. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. Patel S; Freedman S; Chapman KL; Emms F; Fletcher AE; Knowles M; Marwood R; Mcallister G; Myers J; Curtis N; Kulagowski JJ; Leeson PD; Ridgill M; Graham M; Matheson S; Rathbone D; Watt AP; Bristow LJ; Rupniak NM; Baskin E; Lynch JJ; Ragan CI J Pharmacol Exp Ther; 1997 Nov; 283(2):636-47. PubMed ID: 9353380 [TBL] [Abstract][Full Text] [Related]
33. 2-Phenyl-4(5)-[[4-(pyrimidin-2-yl)piperazin-1-yl]methyl]imidazole. A highly selective antagonist at cloned human D4 receptors. Thurkauf A; Yuan J; Chen X; He XS; Wasley JW; Hutchison A; Woodruff KH; Meade R; Hoffman DC; Donovan H; Jones-Hertzog DK J Med Chem; 1997 Jan; 40(1):1-3. PubMed ID: 9016321 [No Abstract] [Full Text] [Related]
34. Aminopyrimidines with high affinity for both serotonin and dopamine receptors. Wustrow D; Belliotti T; Glase S; Kesten SR; Johnson D; Colbry N; Rubin R; Blackburn A; Akunne H; Corbin A; Davis MD; Georgic L; Whetzel S; Zoski K; Heffner T; Pugsley T; Wise L J Med Chem; 1998 Feb; 41(5):760-71. PubMed ID: 9513604 [TBL] [Abstract][Full Text] [Related]
35. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation. Zajdel P; Marciniec K; Maślankiewicz A; Satała G; Duszyńska B; Bojarski AJ; Partyka A; Jastrzębska-Więsek M; Wróbel D; Wesołowska A; Pawłowski M Bioorg Med Chem; 2012 Feb; 20(4):1545-56. PubMed ID: 22277589 [TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents. Norman MH; Rigdon GC; Hall WR; Navas F J Med Chem; 1996 Mar; 39(5):1172-88. PubMed ID: 8676355 [TBL] [Abstract][Full Text] [Related]
38. 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. Kulagowski JJ; Broughton HB; Curtis NR; Mawer IM; Ridgill MP; Baker R; Emms F; Freedman SB; Marwood R; Patel S; Patel S; Ragan CI; Leeson PD J Med Chem; 1996 May; 39(10):1941-2. PubMed ID: 8642550 [No Abstract] [Full Text] [Related]
39. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor. Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773 [TBL] [Abstract][Full Text] [Related]
40. The tertiary amine nitrogen atom of piperazine sulfonamides as a novel determinant of potent and selective beta3-adrenoceptor agonists. Perrone MG; Bleve L; Santandrea E; Vitale P; Niso M; Scilimati A ChemMedChem; 2009 Dec; 4(12):2080-97. PubMed ID: 19882697 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]